• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ON-X LIFE TECHNOLOGIES, INC. ONX AORTIC CONFORM EXT 27/29; HEART-VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ON-X LIFE TECHNOLOGIES, INC. ONX AORTIC CONFORM EXT 27/29; HEART-VALVE, MECHANICAL Back to Search Results
Model Number ONXACE-27/29
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Code Available (3191)
Event Date 06/11/2020
Event Type  Injury  
Manufacturer Narrative
This investigation is currently ongoing.Any additional information will be provided in the follow-up report.
 
Event Description
According to the initial report, onxace-27/29 sn (serial number) (b)(4) was explanted on (b)(6) 2020 and replaced with an onxaap-27/29.
 
Event Description
According to the initial report, onxace-27/29 sn (serial number) (b)(6) was explanted on (b)(6) 2020 and replaced with an onxaap-27/29.
 
Manufacturer Narrative
Attempts to obtain additional information were made with no response.The manufacturing records for onxace-27/29 sn (b)(6) were reviewed and it was confirmed that all records were controlled, available for review, and met all specifications per the device master record.All lots passed functional testing and met release specifications.During the investigation no non-conformances or deviations were noted.Onxace-27/29 sn (b)(6) was implanted (b)(6) 2016 in the aortic position of a 32-year-old male.It was replaced by an onxaap-25 aortic valved conduit on (b)(6) 2020 (3 years 299 days post-implant) in a double valve procedure with onx-32/33 implanted in the mitral position.No other information was made available.Reoperation and explantation are recognized risks associated with complications of prosthetic heart valves [ifu], but in this case we have no evidence to indicate what, if any, contribution the original on-x valve made to the decision for its removal.The event does not identify any additional hazards or modify the probability and severity of existing hazards.An on-x aortic valve was replaced with an on-x aortic valved conduit, but the reason for its removal is unknown.This report is being submitted as required by federal regulations and does not constitute an admission that the device caused or contributed to the reported event.Furthermore, this report reflects the event as alleged by the complainant and does not imply that the information reported to cryolife is accurate or has been confirmed by cryolife.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ONX AORTIC CONFORM EXT 27/29
Type of Device
HEART-VALVE, MECHANICAL
Manufacturer (Section D)
ON-X LIFE TECHNOLOGIES, INC.
1300 e. anderson ln., bldg. b
austin TX 78752
MDR Report Key10355919
MDR Text Key202112419
Report Number1649833-2020-00031
Device Sequence Number1
Product Code LWQ
Combination Product (y/n)N
PMA/PMN Number
P000037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Type of Report Initial,Followup
Report Date 10/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Expiration Date07/01/2022
Device Model NumberONXACE-27/29
Was Device Available for Evaluation? No
Distributor Facility Aware Date07/09/2020
Initial Date Manufacturer Received 07/09/2020
Initial Date FDA Received08/03/2020
Supplement Dates Manufacturer Received07/09/2020
Supplement Dates FDA Received10/09/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age32 YR
-
-